Medicare Enrolled

Dr. Emily Singh, M.D.

Hospitalist Physician · San Diego, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
15004 INNOVATION DR, San Diego, CA 92128
8586057390
In practice since 2006 (19 years)
NPI: 1548370935 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Singh

Dr. Emily Singh is a hospitalist physician in San Diego, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 553 Medicare services across 520 unique beneficiaries.

Between the years covered by Open Payments, Dr. Singh received a total of $7,358 from 39 pharmaceutical and/or device companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 42% volume in CA $7,358 industry payments

Medicare Practice Summary

Medicare Utilization ↗
553
Medicare services
Top 42% in CA for hospitalist physician
520
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~29 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Moderate sedation during GI endoscopy
Sedation services provided by the physician performing a gastrointestinal endoscopic procedure. This requires an independent trained observer to assist in monitoring the patient.
156 $5 $166
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
95 $101 $350
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
83 $116 $1,789
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
45 $90 $1,581
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
43 $130 $453
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
41 $210 $1,840
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
25 $41 $101
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
22 $184 $983
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $68 $248
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
15 $179 $982
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
13 $102 $354
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,358
Total received (2018-2024)
Avg $1,051/year across 7 years
Top 3% in CA for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
355
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,020 (95.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$338 (4.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,437
2023
$1,514
2022
$1,013
2021
$559
2020
$479
2019
$913
2018
$1,444

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$423
Takeda Pharmaceuticals U.S.A., Inc.
$288
Janssen Biotech, Inc.
$160
Regeneron Healthcare Solutions, Inc.
$149
PFIZER INC.
$111
GENZYME CORPORATION
$68
Ardelyx, Inc.
$55
Merck Sharp & Dohme LLC
$52
QOL Medical, LLC
$42
Lilly USA, LLC
$24
IRONWOOD PHARMACEUTICALS, INC
$24
Phathom Pharmaceuticals, Inc.
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$20
Top 3 companies account for 60.6% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$1,310
ABBVIE INC.
$997
AbbVie Inc.
$935
Janssen Biotech, Inc.
$738
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$557
AbbVie, Inc.
$416
PFIZER INC.
$331
Regeneron Healthcare Solutions, Inc.
$302
Allergan Inc.
$230
Celgene Corporation
$149
Janssen Scientific Affairs, LLC
$143
GENZYME CORPORATION
$142
Ardelyx, Inc.
$129
Synergy Pharmaceuticals Inc
$120
Braintree Laboratories, Inc.
$118
Ferring Pharmaceuticals Inc.
$117
QOL Medical, LLC
$100
GlaxoSmithKline, LLC.
$52
Merck Sharp & Dohme LLC
$52
Janssen Pharmaceuticals, Inc
$42
Concordia Pharmaceuticals Inc.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$37
Enterra Medical, Inc.
$26
Lilly USA, LLC
$24
IRONWOOD PHARMACEUTICALS, INC
$24
Otsuka America Pharmaceutical, Inc.
$22
Acorda Therapeutics, Inc
$21
Phathom Pharmaceuticals, Inc.
$20
Allergan, Inc.
$18
Circassia Pharmaceuticals Inc
$18
Dynavax Technologies Corporation
$17
Romark Laboratories, LC
$16
Shionogi Inc
$16
Amgen Inc.
$14
Intercept Pharmaceuticals, Inc.
$14
Gilead Sciences, Inc.
$13
Merck Sharp & Dohme Corporation
$13
Prometheus Laboratories Inc.
$12
PENTAX of America, Inc.
$11
Top 3 companies account for 44.1% of all-time payments
Associated products mentioned in payments ›
Alinia · Amitiza · BREATHTEK · C2 CryoBalloon · CLENPIQ · CREON · CYLTEZO · DIFICID · DUPIXENT · Dexilant · Donnatal · ENTYVIO · Entyvio · GATTEX · HUMIRA · Harvoni · Heplisav-B · Humira · IBSRELA · INBRIJA · INFLECTRA · LINZESS · Linzess · MOTEGRITY · MOTOFEN · Motegrity · Mulpleta · NUCALA · OCALIVA · OFEV · OMVOH · REMICADE · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TUDORZA PRESSAIR · Trintellix · Trulance · UCERIS · VIBERZI · VOQUEZNA · XARELTO · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for hospitalist physician in CA.

Looking for a hospitalist physician in San Diego?
Compare hospitalist physicians in the San Diego area by procedure volume, costs, and industry payment transparency.
Browse hospitalist physicians nearby

Geographic Context

Hospitalist physicians within 10 mi
175
Per 100K population
5.3
County median income
$102,285
Nearest hospital
AURORA SAN DIEGO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Singh is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 3% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Singh experienced with moderate sedation during gi endoscopy?
Based on Medicare claims data, Dr. Singh performed 156 moderate sedation during gi endoscopy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $7,358 from 39 companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other hospitalist physicians in San Diego?
Dr. Singh's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →